Health & Nutritional Stocks in the News - Company Expands Product Diversity Based on Growing Consumer Demand

 Health & Nutritional Stocks in the News - Company Expands Product Diversity
                       Based on Growing Consumer Demand

PR Newswire

CORAL SPRINGS, Florida, February 25, 2014

CORAL SPRINGS, Florida, February 25, 2014 /PRNewswire/ --

Consumer goods & bio/pharma companies draw attention from investors with
increased production and news developments: RiceBran Technologies (NASDAQ:
RIBT), Mondelez International, Inc. (NASDAQ: MDLZ), Whole Foods Market, Inc.
(NASDAQ: WFM), Inovio Pharmaceuticals, Inc. (NYSE: INO) and VIVUS Inc.

RiceBran Technologies (NASDAQ: RIBT) ("RBT"), a global leader in the
production and marketing of value added products derived from rice bran, today
announced that RBT is exhibiting at Booth #8623 at the upcoming Natural
Products Expo West trade show from March 7 to March 9, 2014 at the Anaheim
Convention Center in Anaheim, California. RBT will exhibit its range of
minimally processed, hypo-allergenic, gluten free, non-GMO stabilized rice
bran ingredients and patented rice bran derivatives at Natural Products Expo
West, the leading trade show in the natural, organic and healthy products
industry.Natural Products Expo West is expected to attract over 60,000
industry professionals and 3,000 exhibitors to the Anaheim Convention Center.

Dr. Robert Smith, SVP of Sales and Business Development for RBT commented,
"Based on growing consumer demand for highly nutritious, gluten-free, vegan
and minimally processed products, Natural Products Expo West is the ideal
venue for exhibiting our proprietary and patented rice bran and derivative
products. We will be highlighting the health and nutritional benefits that can
be achieved by incorporating our ingredients into a diverse range of healthy
foods from beverages, nutrition bars, cereals, and pastas to high-end
companion pet nutrition products."

To read the full press release, please click

W. John Short, CEO & President of RBT commented "Natural Products Expo West
provides an excellent opportunity to highlight the enhanced capabilities
resulting from our recent acquisition of H&N Distribution. In addition to
delivering our individual functional ingredients, we are now in a position to
provide turnkey, packaged finished product offerings to a variety of retail,
direct-to-consumer and direct marketing customers based on our proprietary and
patented ingredients blended with other sources of proteins and phytonutrients
to produce healthy and natural products that compete effectively in the health
and wellness markets."

Mondelez International, Inc. (NASDAQ: MDLZ) recently highlighted the company's
competitive advantages, long-term growth targets and margin-improvement
initiatives at the Consumer Analyst Group of New York (CAGNY) conference. The
company also provided detailed insights into the performance and outlook of
its North American business. "With an unrivaled portfolio of iconic brands,
leading share positions in all of our key categories and an advantaged
geographic footprint, we have the best set of assets in our industry," said
Irene Rosenfeld, Chairman and CEO. "The plans we're executing now will enable
us over the long term to deliver strong top-line growth, significantly expand
margins, grow Adjusted EPS double digits and continue to generate solid cash
flow. We believe these efforts will drive top-tier shareholder returns." 

Whole Foods Market, Inc. (NASDAQ: WFM) has committed more than $5 million to
fight poverty in the U.S. through its partner,Grameen America, a nonprofit
microfinance organization that offers microloans, training and support to help
women who live in poverty build small businesses to create better lives for
their families. The money will help Grameen America launch a new microlending
branch in Austin, and will support existing programs in six metro areas: New
York; the Bay Area; Los Angeles; Charlotte, N.C.; Omaha, Neb.; and
Indianapolis. To date, Whole Planet Foundation has committed more than $48
million for microcredit projects throughout 59 countries across Asia, Africa
and the Americas. 

Inovio Pharmaceuticals, Inc. (NYSE: INO) recentlyannounced it has expanded
its senior management team with two appointments to help advance the company's
growing pipeline of preclinical and clinical DNA vaccines. Inovio has
appointed Dr. Laurent Humeau as Vice President of R&D and Dr. Jan Marie-Albert
Van Tornout as Vice President of Clinical Development. Prior to Inovio, Dr.
Humeau was Senior Director of Translational Research, Human Therapeutics
Division for Intrexon and previously Chief Scientific Officer at VIRxSYS
Corporation. At Inovio, Dr. Humeau will provide the technical and strategic
leadership for its R&D group including: preclinical development of
immunotherapy and vaccine candidates, immunology and immune monitoring
approaches, method development, product characterization, and analytical

VIVUS Inc. (NASDAQ: VVUS) a biopharmaceutical company commercializing
Qsymia®(phentermine and topiramate extended-release) capsules CIV for the
treatment of obesity, recently provided a business update and reported its
financial results for the fourth quarter and year ended December 31, 2013. On
November 13, 2013, we announced that the United States Patent and Trademark
Office had issued U.S. Patent Nos. 8,580,298, covering compositions of Qsymia,
and 8,580,299, covering methods for effecting weight loss using Qsymia. The
newly issued patents are assigned to VIVUS and are expected to extend patent
exclusivity for Qsymia in the U.S. to 2029.

FinancialNewsMedia.comis leading provider of third party publishing &news
dissemination services.If you would like more information regarding our news
coverage solutions, please visit for more
details.Get an edge on the market with ourPremium News Alertsthat are FREE
for a limited time at us on

DISCLAIMER:FN Media Group LLC (FNMG) is a third party publisher and news
dissemination service provider, which disseminates electronic information
through multiple online media channels. FNMG is NOT affiliated in any manner
with any company mentioned herein.FNMG and its affiliated companies are a
news dissemination and financial marketing solutions provider and are NOT a
registered broker/dealer/analyst/adviser, holds no investment licenses and may
NOT sell, offer to sell or offer to buy any security.FNMG's market updates,
news alerts and corporate profiles are NOT a solicitation or recommendation to
buy, sell or hold securities.The material in this release is intended to be
strictly informational and is NEVER to be construed or interpreted as research
material. All readers are strongly urged to perform research and due diligence
on their own and consult a licensed financial professional before considering
any level of investing in stocks. The companies that are discussed in this
release may or may not have approved the statements made in this release. FNMG
is not liable for any investment decisions by its readers or
subscribers.Investors are cautioned that they may lose all or a portion of
their investment when investing in stocks. For current services performed FNMG
has been compensated one thousand five hundred dollars for news coverage of
the current press release issued by RiceBran Technology by the company.


This release contains "forward-looking statements" within the meaning of
Section 27A of the Securities Act of 1933, as amended, and Section 21E the
Securities Exchange Act of 1934, as amended and such forward-looking
statements are made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. "Forward-looking statements"
describe future expectations, plans, results, or strategies and are generally
preceded by words such as "may", "future", "plan" or "planned", "will" or
"should", "expected," "anticipates", "draft", "eventually" or "projected". You
are cautioned that such statements are subject to a multitude of risks and
uncertainties that could cause future circumstances, events, or results to
differ materially from those projected in the forward-looking statements,
including the risks that actual results may differ materially from those
projected in the forward-looking statements as a result of various factors,
and other risks identified in a company's annual report on Form 10-K or 10-KSB
and other filings made by such company with the Securities and Exchange
Commission. You should consider these factors in evaluating the
forward-looking statements included herein, and not place undue reliance on
such statements. The forward-looking statements in this release are made as of
the date hereof and FNMG undertakes no obligation to update such statements.

Contact Information:
Company:FN Media Group, LLC
Contact email:
U.S. Phone: +1(954)345-0611

SOURCE FN Media Group, LLC
Press spacebar to pause and continue. Press esc to stop.